Sunday, March 29, 2020

Strides Pharma Science receives EIR for Bengaluru facility from USFDA

Strides Pharma Science receives EIR for Bengaluru facility from USFDA The inspection by the US Food and Drug Administration (USFDA) was related to specific extended release applications made from the site. Receipt of EIR confirms the successful closure of the inspections, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3azrdms
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Will proposed US tariffs trigger further Indian market decline? Experts weigh in

Indian stock markets experienced a significant drop on Thursday, with major indices falling around 1 percent. This decline, the steepest sin...